Emmessar Biotech & Nutrition Limited (BOM:524768)
India flag India · Delayed Price · Currency is INR
25.10
+0.54 (2.20%)
At close: Mar 10, 2026

BOM:524768 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Net Income
-3.167.55.044.7514.5
Upgrade
Depreciation & Amortization
-0.980.980.940.920.58
Upgrade
Other Operating Activities
-1.55-4.392.78-0.545.75
Upgrade
Change in Accounts Receivable
-0.05-0.120.0226.97-26.84
Upgrade
Change in Inventory
--0.350.47-0.68-0.0110.82
Upgrade
Change in Accounts Payable
--0.060.09-0.22-4.75-3.08
Upgrade
Change in Other Net Operating Assets
--3.091.92-4.11-4.652.94
Upgrade
Operating Cash Flow
-2.246.453.7622.74.68
Upgrade
Operating Cash Flow Growth
--65.28%71.34%-83.43%385.13%-54.60%
Upgrade
Capital Expenditures
----0.26-3.06-0.02
Upgrade
Investment in Securities
--6.92-9.9-7.79-24.58-1.14
Upgrade
Other Investing Activities
-4.633.472.591.491.24
Upgrade
Investing Cash Flow
--2.3-6.44-5.46-26.140.08
Upgrade
Other Financing Activities
-0.04----
Upgrade
Financing Cash Flow
-0.04----
Upgrade
Net Cash Flow
--0.030.01-1.7-3.454.76
Upgrade
Free Cash Flow
-2.246.453.519.644.66
Upgrade
Free Cash Flow Growth
--65.28%84.22%-82.19%321.44%-54.75%
Upgrade
Free Cash Flow Margin
-10.48%31.57%13.91%110.78%5.51%
Upgrade
Free Cash Flow Per Share
-0.451.290.703.930.93
Upgrade
Cash Interest Paid
-0.01----
Upgrade
Cash Income Tax Paid
-0.17-0.2-0.62-2.921
Upgrade
Levered Free Cash Flow
-14.864.50.6816.642.33
Upgrade
Unlevered Free Cash Flow
-14.874.50.6816.642.33
Upgrade
Change in Working Capital
--3.452.36-4.9917.57-16.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.